News

4D Molecular Therapeutics gets FDA RMAT status for macular edema treatment
D Molecular Therapeutics (NASDAQ:FDMT) achieves FDA RMAT status for 4D-150 as a diabetic macular edema treatment, backed by ...
PharmiWeb3d
What Triggers Edema and How the Right Medication Can Help You Recover
Edema is a medical condition characterized by the accumulation of excess fluid in the body’s tissues, leading to swelling and ...